Cited by 197Estrogen and related hormone effectsSmoking Behavior and CessationEffects and risks of endocrine disrupting chemicals

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index; none of the 21 sources its claims cite is checked for support yet.

Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.

Open access
Barbieri, R L, Gochberg, J, Ryan, K J·1986·Journal of Clinical Investigation

Abstract

Epidemiologic studies suggest that women who smoke have lower endogenous estrogen than nonsmokers. To explore the possible link between cigarette smoking and decreased endogenous estrogens, we have examined the effects of constituents of tobacco on estrogen production in human choriocarcinoma cells and term placental microsomes. In choriocarcinoma cell cultures, nicotine, cotinine (a major metabolite of nicotine), and anabasine (a minor component of cigarette tobacco) all inhibited androstenedione conversion to estrogen in a dose-dependent fashion. Removal of nicotine, cotinine, and anabasine from the culture medium resulted in the complete reversal of the inhibition of aromatase. In the choriocarcinoma cell cultures, a supraphysiologic concentration of androstenedione (73 microM) in the culture medium blocked the inhibition of aromatase caused by nicotine, cotinine, and anabasine. In preparations of term placental microsomes, nicotine, cotinine, and anabasine inhibited the conversion of testosterone to estrogen. Kinetic analysis demonstrated the inhibition to be competitive with respect to the substrate. These findings suggest that some nicotinic alkaloids directly inhibit aromatase. This mechanism may explain, in part, the decreased estrogen observed in women who smoke.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci112494

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 21 cited sources checked · 0 supported · 0 flagged

Show all 61 claims

  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 5
  • The quote only partly states this claim. 1
14 of 14
  • The authors state this as an assumption.

    The aromatase enzyme system in human granulosa cells is similar to placental aromatase.

    “If the granulosa cell and placental aromatase are similar, then the in vitro observation that nicotine and cotinine”
  • The paper relies on this without support.

    The concentrations of nicotine and cotinine in body fluids reflect their concentrations at the aromatase enzyme site in ovarian or placental tissues.

    “The nicotine and cotinine concentrations present in ovarian follicular fluid and in steroidogenic tissues of women who smoke have not been reported.However, the concentrations of nicotine and cotinine that have been re- ported to be present in the body fluids of women who smoke suggests that the in vitro findings reported here may have relevance in vivo.”
  • The paper relies on this without support.

    In the follicular phase of the menstrual cycle, the circulating androstenedione concentration is approximately 5 nM.

    “In the follicular phase of the menstrual cycle, the circulating androstenedione concentration is -5 nM.”
  • The paper relies on this without support.

    In the luteal phase of the menstrual cycle, the basement membrane of the dominant follicle is disrupted and the follicular microenvironment is lost.

    “In contrast, in the luteal phase of the menstrual cycle, the basement membrane of the dominant follicle is disrupted, and the follicular microenvironment is lost.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

2 of the 35 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 197

Metadata

Authors
Barbieri, R. L., Gochberg, J., & Ryan, K. J.
Affiliations
Brigham and Women's Hospital (US)
Venue
Journal of Clinical Investigation
Published
1986-06-01
Volume
77
Issue
6
Pages
1727-1733
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2115000106
Cited by
197
References
35
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 8 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 10 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 9 · 2013: 5 · 2012: 13
FWCI
3.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD18292)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords
nicotine, cotinine, anabasine, aromatase inhibition, tobacco smoke, estrogen synthesis, choriocarcinoma cells, placental microsomes, androstenedione, testosterone, competitive inhibition, endogenous estrogen
MeSH terms
Anabasine, Androstenedione, Carbachol, Cells, Cultured, Choriocarcinoma, Cotinine, Decamethonium Compounds, Dose-Response Relationship, Drug, Estradiol, Female, Hexamethonium Compounds, Humans, Kinetics, Microsomes, Nicotine, Piperidines, Placenta, Pregnancy, Pyrrolidinones, Smoking, Succinylcholine, Trophoblasts, Uterine Neoplasms, Aromatase Inhibitors, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review